Coya Therapeutics raised $11.1 million to support manufacturing scale-up for its experimental ALS therapy, COYA 302.
Goethe University Frankfurt, University Hospital, Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Frankfurt am Main, Germany In this study, an extended analysis of ...
BMY jumps after strong Q4 2025 results as its growth portfolio drives beats, lifts sentiment and offsets generic pressure on legacy drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results